These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1065 related items for PubMed ID: 30556506

  • 1. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS, Prasad YR, Shaik AB.
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [Abstract] [Full Text] [Related]

  • 2. New INH-pyrazole analogs: Design, synthesis and evaluation of antitubercular and antibacterial activity.
    Nayak N, Ramprasad J, Dalimba U.
    Bioorg Med Chem Lett; 2015 Dec 01; 25(23):5540-5. PubMed ID: 26520663
    [Abstract] [Full Text] [Related]

  • 3. Tryptanthrin Analogues as Inhibitors of Enoyl-acyl Carrier Protein Reductase: Activity against Mycobacterium tuberculosis, Toxicity, Modeling of Enzyme Binding.
    Duca G, Pogrebnoi S, Boldescu V, Aksakal F, Uncu A, Valica V, Uncu L, Negres S, Nicolescu F, Macaev F.
    Curr Top Med Chem; 2019 Dec 01; 19(8):609-619. PubMed ID: 30834838
    [Abstract] [Full Text] [Related]

  • 4. Development of gallic acid formazans as novel enoyl acyl carrier protein reductase inhibitors for the treatment of tuberculosis.
    Saharan VD, Mahajan SS.
    Bioorg Med Chem Lett; 2017 Feb 15; 27(4):808-815. PubMed ID: 28117201
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Thiazole-Chalcone Hybrids as Prospective Antitubercular and Antiproliferative Agents: Design, Synthesis, Biological, Molecular Docking Studies and In Silico ADME Evaluation.
    Kasetti AB, Singhvi I, Nagasuri R, Bhandare RR, Shaik AB.
    Molecules; 2021 May 11; 26(10):. PubMed ID: 34064806
    [Abstract] [Full Text] [Related]

  • 7. Discovery of hydrazone containing thiadiazoles as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
    Doğan H, Doğan ŞD, Gündüz MG, Krishna VS, Lherbet C, Sriram D, Şahin O, Sarıpınar E.
    Eur J Med Chem; 2020 Feb 15; 188():112035. PubMed ID: 31951850
    [Abstract] [Full Text] [Related]

  • 8. Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties.
    Joshi SD, Dixit SR, Kirankumar MN, Aminabhavi TM, Raju KV, Narayan R, Lherbet C, Yang KS.
    Eur J Med Chem; 2016 Jan 01; 107():133-52. PubMed ID: 26580979
    [Abstract] [Full Text] [Related]

  • 9. Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme.
    Venugopala KN, Chandrashekharappa S, Deb PK, Tratrat C, Pillay M, Chopra D, Al-Shar'i NA, Hourani W, Dahabiyeh LA, Borah P, Nagdeve RD, Nayak SK, Padmashali B, Morsy MA, Aldhubiab BE, Attimarad M, Nair AB, Sreeharsha N, Haroun M, Shashikanth S, Mohanlall V, Mailavaram R.
    J Enzyme Inhib Med Chem; 2021 Dec 01; 36(1):1472-1487. PubMed ID: 34210233
    [Abstract] [Full Text] [Related]

  • 10. Design, synthesis, in silico and in vitro evaluation of novel diphenyl ether derivatives as potential antitubercular agents.
    Tiwari AP, Sridhar B, Boshoff HI, Arora K, Gautham Shenoy G, Vandana KE, Varadaraj Bhat G.
    Mol Divers; 2020 Nov 01; 24(4):1265-1279. PubMed ID: 31506871
    [Abstract] [Full Text] [Related]

  • 11. New coumarin linked thiazole derivatives as antimycobacterial agents: Design, synthesis, enoyl acyl carrier protein reductase (InhA) inhibition and molecular modeling.
    Kassem AF, Sabt A, Korycka-Machala M, Shaldam MA, Kawka M, Dziadek B, Kuzioła M, Dziadek J, Batran RZ.
    Bioorg Chem; 2024 Sep 01; 150():107511. PubMed ID: 38870705
    [Abstract] [Full Text] [Related]

  • 12. Novel Benzylidenehydrazide-1,2,3-Triazole Conjugates as Antitubercular Agents: Synthesis and Molecular Docking.
    Shaikh MH, Subhedar DD, Nawale L, Sarkar D, Khan FAK, Sangshetti JN, Shingate BB.
    Mini Rev Med Chem; 2019 Sep 01; 19(14):1178-1194. PubMed ID: 30019644
    [Abstract] [Full Text] [Related]

  • 13. Virtual screening and synthesis of novel antitubercular agents through interaction-based pharmacophore and molecular docking studies.
    Bhattarai D, Muddassar M, Jang JW, Hong SK, Kim EE, Oh T, Cho SN, Pae AN, Keum G.
    Curr Comput Aided Drug Des; 2014 Sep 01; 10(4):383-92. PubMed ID: 25872944
    [Abstract] [Full Text] [Related]

  • 14. 4-Aryl-1,4-Dihydropyridines as Potential Enoyl-Acyl Carrier Protein Reductase Inhibitors: Antitubercular Activity and Molecular Docking Study.
    Venugopala KN, Deb PK, Pillay M, Chopra D, Chandrashekharappa S, Morsy MA, Aldhubiab BE, Attimarad M, Nair AB, Sreeharsha N, Kandeel M, Venugopala R, Mohanlall V.
    Curr Top Med Chem; 2021 Sep 01; 21(4):295-306. PubMed ID: 33138763
    [Abstract] [Full Text] [Related]

  • 15. Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA.
    Pedgaonkar GS, Sridevi JP, Jeankumar VU, Saxena S, Devi PB, Renuka J, Yogeeswari P, Sriram D.
    Bioorg Med Chem; 2014 Nov 01; 22(21):6134-45. PubMed ID: 25282650
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and in vitro antimycobacterial activity of N1-nicotinoyl-3-(4'-hydroxy-3'-methyl phenyl)-5-[(sub)phenyl]-2-pyrazolines.
    Shaharyar M, Siddiqui AA, Ali MA, Sriram D, Yogeeswari P.
    Bioorg Med Chem Lett; 2006 Aug 01; 16(15):3947-9. PubMed ID: 16725324
    [Abstract] [Full Text] [Related]

  • 17. Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
    Desai NC, Somani H, Trivedi A, Bhatt K, Nawale L, Khedkar VM, Jha PC, Sarkar D.
    Bioorg Med Chem Lett; 2016 Apr 01; 26(7):1776-83. PubMed ID: 26920799
    [Abstract] [Full Text] [Related]

  • 18. Synthesis, Characterization and Biological Evaluation of New 3,5-Disubstituted-Pyrazoline Derivatives as Potential Anti-Mycobacterium tuberculosis H37Ra Compounds.
    Wong KT, Osman H, Parumasivam T, Supratman U, Che Omar MT, Azmi MN.
    Molecules; 2021 Apr 05; 26(7):. PubMed ID: 33916423
    [Abstract] [Full Text] [Related]

  • 19. N-Benzyl-4-((heteroaryl)methyl)benzamides: A New Class of Direct NADH-Dependent 2-trans Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors with Antitubercular Activity.
    Guardia A, Gulten G, Fernandez R, Gómez J, Wang F, Convery M, Blanco D, Martínez M, Pérez-Herrán E, Alonso M, Ortega F, Rullás J, Calvo D, Mata L, Young R, Sacchettini JC, Mendoza-Losana A, Remuiñán M, Ballell Pages L, Castro-Pichel J.
    ChemMedChem; 2016 Apr 05; 11(7):687-701. PubMed ID: 26934341
    [Abstract] [Full Text] [Related]

  • 20. Structure-based design of some isonicotinic acid hydrazide analogues as potential antitubercular agents.
    Atta A, Fahmy S, Rizk O, Sriram D, Mahran MA, Labouta IM.
    Bioorg Chem; 2018 Oct 05; 80():721-732. PubMed ID: 30077175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.